• Pexmetinib (ARRY-614): Structural Insights for Inhibiting Cy

  2026-04-20

  Explore how Pexmetinib (ARRY-614) leverages conformational kinase control for superior inflammatory cytokine inhibition and myelodysplastic syndromes research. This article offers a structural and mechanistic lens on dual inhibition and assay optimization.

• Applied Workflows with EZ Cap™ Human PTEN mRNA in Cancer Res

  2026-04-19

  EZ Cap™ Human PTEN mRNA empowers researchers to restore PTEN function with superior mRNA stability and expression, enabling advanced cancer research and gene therapy applications. This guide delivers actionable protocols, troubleshooting insights, and real-world innovations rooted in the latest delivery science.

• HyperScribe™ T7 Cy5 RNA Labeling Kit: Precision Probes for A

  2026-04-18

  Explore how the HyperScribe T7 High Yield Cy5 RNA Labeling Kit empowers the next generation of in situ fluorescent RNA probes for dissecting efferocytosis and inflammation. This article uniquely bridges advanced RNA labeling with mechanistic insights from recent macrophage-targeted therapies.

• S63845 MCL1 Inhibitor: Precision Apoptosis Control in Hemato

  2026-04-17

  Explore the distinct role of S63845, a potent MCL1 inhibitor, in modulating BAX/BAK-dependent apoptosis for advanced hematological cancer research. This article uniquely integrates mechanistic rigor with practical assay insights, extending beyond conventional guidance.

• TNF-alpha Recombinant Murine Protein: Decoding Apoptotic Sig

  2026-04-16

  Explore the unique role of TNF-alpha recombinant murine protein in mediating apoptosis and inflammation through advanced signaling pathways. This article offers a novel, evidence-driven perspective for researchers seeking to optimize cytokine-driven cell death assays.

• Homoharringtonine: Cytotoxic Alkaloid for Cancer & Antiviral

  2026-04-15

  Homoharringtonine stands out as a versatile cytotoxic alkaloid for both leukemia research and rapid antiviral screening, offering robust inhibition of protein synthesis in eukaryotic cells. This article breaks down optimized workflows, troubleshooting tips, and unique protocol parameters to unlock reproducible results across cancer biology and SARS-CoV-2 research.

• TCF25 Orchestrates Lysosomal Acidification in Glucose Starva

  2026-04-14

  Ren et al. (2025) identify TCF25 as a nutrient sensor that regulates lysosomal acidification and cell fate during glucose starvation by modulating V-ATPase activity. Their findings reveal a crucial link between metabolic adaptation, autophagy, and lysosome-dependent cell death, presenting new avenues for targeting metabolic vulnerabilities in disease.

• Applied Precision: HotStart Universal 2X Green qPCR Master M

  2026-04-13

  HotStart™ Universal 2X Green qPCR Master Mix empowers researchers with a robust, antibody-mediated hot-start Taq polymerase platform for reproducible, dye-based gene expression analysis. Its universal ROX compatibility and built-in Green I dye streamline real-time PCR workflows, as exemplified by advanced studies in animal nutrition and translational genetics.

• Optimizing Protein Labeling with Cy5 Maleimide (Non-sulfonat

  2026-04-12

  Cy5 maleimide (non-sulfonated) enables reproducible, high-contrast fluorescent labeling of proteins—crucial for advanced imaging and partitioning studies. This guide translates recent research and expert workflow strategies into actionable steps to maximize specificity and sensitivity in your fluorescence assays.

• Monomethyl Auristatin E (MMAE): Precision Payloads for Overc

  2026-04-12

  Discover how Monomethyl auristatin E (MMAE) is redefining targeted cancer therapy by bridging cytotoxic precision with emerging insights into cancer cell plasticity and differentiation. This article uniquely analyzes MMAE's role in next-generation antibody-drug conjugates and guides researchers on practical assay decisions.

• Toremifene Citrate: Protocol-Driven Advances in Breast Cance

  2026-04-11

  Toremifene Citrate stands out as an oral selective estrogen receptor modulator, driving reproducible, high-confidence results in estrogen receptor and breast cancer research. This guide translates peer-reviewed findings and hands-on protocols into actionable workflows, troubleshooting strategies, and advanced applications, empowering researchers to maximize assay sensitivity and data integrity.

• SB 431542: Precision ALK5 Inhibitor for TGF-β Pathway Resear

  2026-04-11

  SB 431542 stands out as a highly selective ALK5 inhibitor, enabling targeted modulation of the TGF-β signaling pathway in complex cellular and animal models. Its robust efficacy in suppressing Smad2 phosphorylation and versatile application across oncology, vascular biology, and immunology research underscores its unique value for experimental design.

• Bazedoxifene (SKU A3232): Scenario-Driven Solutions for R...

  2026-04-10

  This in-depth, scenario-based guide demonstrates how Bazedoxifene (SKU A3232) from APExBIO addresses reproducibility, selectivity, and workflow reliability in cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed research and real laboratory challenges, the article provides actionable protocols and vendor guidance for scientists seeking robust performance and data integrity.

• Bazedoxifene: Advanced SERM Workflows for Osteoporosis Re...

  2026-04-09

  Bazedoxifene, a third-generation selective estrogen receptor modulator, elevates osteoporosis research with precise ERα and ERβ modulation, potent bone mineral density enhancement, and emerging antimalarial potential. Leverage this tissue-selective SERM from APExBIO for robust in vitro and in vivo workflows, informed troubleshooting, and a future-forward approach to estrogen receptor signaling studies.

• Bazedoxifene: Advanced SERM for Postmenopausal Osteoporos...

  2026-04-08

  Bazedoxifene stands out as a third-generation selective estrogen receptor modulator (SERM), uniquely enabling precise modulation of estrogen receptor signaling in bone, cancer, and antimalarial models. Its nanomolar potency, tissue-selectivity, and proven efficacy in both osteoporosis and emerging disease paradigms make it indispensable for translational and mechanistic research.

406 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page